Finance Home - My Yahoo - Yahoo! - Help

Friday, December 25, 2009, 1:52PM ET - U.S. Markets Closed for Christmas. Dow  0.51% Nasdaq  0.71%

Transcept Pharmaceuticals, Inc. (TSPT)

On Dec 24: 6.56   0.08 (1.23%)

MORE ON TSPT

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Company Events Get Company Events for:
UPCOMING EVENTS   Date Event Reminder No Upcoming Events RECENT EVENTS   Date Event 15-Dec-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits 24-Nov-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits 19-Nov-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K/A, Costs Associated with Exit or Disposal Activities, Financial Stat 16-Nov-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report 12-Nov-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements 4-Nov-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits 29-Oct-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits 19-Oct-09 Price hit new 52-week high ($15.40) 6-Oct-09 Price hit new 52-week high ($15.00) 5-Oct-09 Price hit new 52-week high ($14.90) 19-Aug-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Regulation FD Di 14-Aug-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements 4-Aug-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits 3-Aug-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosur 18-Jun-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement 11-Jun-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits 10-Jun-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits 9-Jun-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and 15-May-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report 13-May-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements 23-Apr-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers 9-Apr-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an 31-Mar-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K/A, Financial Statements and Exhibits 31-Mar-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an 23-Mar-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements 13-Mar-09 Price hit new 52-week low ($2.56) 9-Mar-09 Price hit new 52-week low ($2.95) 26-Feb-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi 25-Feb-09 Price hit new 52-week low ($3.00) 19-Feb-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers 10-Feb-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement 5-Feb-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi 2-Feb-09 TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Results of Oper
Add to Portfolio     Set Alert     Email to a Friend Get Company Events for Another Symbol: Symbol Lookup • Splits Calendar • Mergers & Acquisitions Calendar